Pharmacodynamics and arteriovenous difference of intravenous naloxone in healthy volunteers exposed to remifentanil

European Journal of Clinical Pharmacology
Ida TylleskarOla Dale

Abstract

Pharmacodynamic studies of naloxone require opioid agonism. Steady state condition may be achieved by remifentanil TCI (target controlled infusion). Opioid agonism can be measured by pupillometry. It is not known whether there are arteriovenous concentration differences for naloxone. The aim was thus to further develop a model for studying pharmacokinetic/pharmacodynamic aspects of naloxone and to explore whether a significant arteriovenous concentration difference for naloxone in humans was present. Relevant authorities approved this study. Healthy volunteers (n = 12) were given 1.0 mg intravenous (IV) naloxone after steady state opioid agonism was obtained by TCI of remifentanil (1.3 ng/ml). Opioid effect was measured by pupillometry. Arterial and venous samples were collected simultaneously before and for 2 h after naloxone administration for quantification of naloxone and remifentanil. Arterial remifentanil was in steady state at 12 min. One milligram IV naloxone reversed the effect of remifentanil to 93% of pre-opioid pupil-size within 4 min. The estimated duration of antagonism was 118 min. At that time, the concentration of naloxone was 0.51 ng/ml. The time course of arterial and venous serum concentrations for naloxone ...Continue Reading

References

Jan 1, 1992·Journal of Psychiatric Research·N LoimerH R Chaudhry
Oct 1, 1991·European Journal of Drug Metabolism and Pharmacokinetics·V P ShahR D McDowall
Feb 1, 1995·Journal of Pharmaceutical and Biomedical Analysis·D DadgarJ W Hooper
Apr 1, 1994·The International Journal of the Addictions·N LoimerH R Chaudhry
May 26, 1999·Clinical Pharmacology and Therapeutics·D J HermannK T Muir
Mar 4, 2000·Journal of Pharmaceutical and Biomedical Analysis·J BenderC van der Heiden
Sep 15, 2001·Clinical Pharmacology and Therapeutics·K M RentschK Fattinger
Jan 9, 2008·European Journal of Clinical Pharmacology·Kristin MoksnesOla Dale
Nov 20, 2009·Anesthesia and Analgesia·Marek BrzezinskiMartin J London
May 25, 2012·Psychopharmacology·William W StoopsSharon L Walsh
Jul 30, 2014·Anesthesiology·Mark D RollinsMerlin Larson
Apr 17, 2016·Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology·Matt S Friedman, Alex F Manini
Feb 2, 2017·European Journal of Clinical Pharmacology·Ida TylleskarOla Dale
Mar 24, 2018·European Journal of Clinical Pharmacology·Arne Kristian SkulbergOla Dale

❮ Previous
Next ❯

Methods Mentioned

BETA
contraception
Blood Collection

Clinical Trials Mentioned

NCT02405988

Software Mentioned

Nonlin Standard
SPSS
Win

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists
A J HartG K Isbister
Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences
Chuan-ya XuWei Lu
© 2022 Meta ULC. All rights reserved